EyeWorld Weekly, July 31, 2026

➤ FDA approval for treatment of wet AMD ➤ Patient enrollment complete for 510(k) pivotal study for microshunt ➤ Key findings in using PROSE for NK ➤ Successful End-of-Phase 1 Type B meeting for non-atropine eye drop ➤ Digital journal invites original case report submissions ➤ Company news ➤ ASCRS news and events